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Abstract
Background. The opioid epidemic is a public health emergency that requires collaboration
between both private and public sectors to increase access to and capacity for efforts directed at
treatment, prevention, and recovery. The Commonwealth of Kentucky via funding from the
Substance Abuse and Mental Health Services Administration (SAMHSA) created their State
Targeted Response to the Opioid Crisis (Opioid STR) in order to help address these needs. The
University of Kentucky, as an awardee of these funds, decided on an approach to highlight the
Emergency Department (ED) bridge model, which links patients discharged from EDs and the
hospital (inpatient addiction consult and education service) to treatment and recovery support
services. One aspect of this model was the creation of the First Bridge Clinic, an outpatient
clinic, which aims to minimize barriers to medications for opioid use disorder (MOUD) as well
as to provide immediate evaluation, initiation, or continuation of MOUD treatment prior to
“bridging” the patients to ongoing comprehensive treatment in the community.
Purpose. This capstone created a descriptive profile of patients referred to and engaging in this
unique clinic. It also examined whether in-hospital initiation of MOUD or other demographic
and clinical characteristics increase the likelihood of not only patients being scheduled for an
intake appointment with the First Bridge Clinic, but also the likelihood of them actually keeping
their first appointments.
Methods. A retrospective chart review of clinical data was performed. Demographic
characteristics including age, sex, race, pregnancy status, veteran status, history of incarceration,
homelessness, initiation of medications for OUD, type of MOUD, and the number of referrals
received per yearly quarter were analyzed by descriptive statistics on all those who received a
referral, those who received an appointment, and those who kept their appointments. Two-

3

sample t-tests and chi-square tests were used to compare characteristics of those who received
and kept appointments. Logistic regression modeling was performed to examine predictor
variables for scheduling a First Bridge Clinic appointment as well as for actually keeping the
first appointment.
Results. The clinic serves a largely Caucasian population with an average age of 36 years old.
People who had recently been released from a correctional facility or homeless individuals were
found to be less likely to receive an appointment to the First Bridge Clinic. While people who
were on MOUD at the time of referral were more likely to receive an appointment at the First
Bridge Clinic, they were not more likely to keep their first appointment. Overall, there was an
upward trend demonstrated over the time period of the analysis in the utilization of the clinic
demonstrating a need for the services provided.
Conclusions and Implications for Public Health Practice. Results indicate that 1) state-level
regulations for MOUD initiation may make implementation of this model more challenging in
the fast-paced environment of the ED, and 2) the rural population largely served by
UKhealthcare establishments may face significant barriers to follow up care. Providing same or
next day outpatient appointments could potentially increase the likelihood these patients are able
to initiate outpatient care.

Keywords: opioid use disorder, OUD, bridge, emergency department, engagement, treatment,
recovery
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Introduction

The opioid epidemic is a public health emergency that requires expanded efforts to
increase access to treatment, prevention, and recovery support services. SAMHSA funded the
Commonwealth of Kentucky via the State Targeted Response to the Opioid Crisis Grant (Opioid
STR) in order to help with the implementation of clinical services that would increase access to
evidence-based medication treatment for opioid use disorder (MOUD), which decreases
mortality but is underutilized. Two new services at the University of Kentucky (UK) were
funded as a result - the outpatient First Bridge Clinic and the inpatient Addiction Consult and
Education Service (ACES).
UK’s First Bridge Clinic launched in 2018. This outpatient clinic aims to minimize
barriers to MOUD and provide immediate evaluation and treatment (or continued treatment if
MOUD already initiated) to patients discharging from the two emergency departments or
inpatient hospitals of UK HealthCare (UKHC). Treatment at the First Bridge Clinic is
comprehensive and interdisciplinary. In addition to providing FDA-approved pharmacotherapy
for opioid use disorder (OUD), there are nurse navigators, harm reduction services, group and
individual counseling, and peer and recovery support services. Clinical care data has been
collected since its inception as part of the requirements of the funding agency, but also for
clinical team meetings/rounding.
The inpatient Addiction Consult and Education Service (ACES) was also created using
state Opioid STR funding as a means to provide inpatient addiction medicine treatment services
and recovery support resources to those hospitalized at UKHC with comorbid substance use
disorders. For persons with OUD, ACES provides MOUD initiation and linkage to ongoing
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outpatient treatment. ACES includes case management, overdose education and naloxone
distribution, group and individual counseling, and peer and recovery support services. Similar
data variables as those collected for the UK First Bridge Clinic have been collected and reported
to the state.
The purpose of this study is to conduct a retrospective chart review of patients receiving
care through the First Bridge Clinic to augment previously collected data and to prepare an
analysis of populations served and early outcomes regarding treatment initiation and
engagement. These novel services are of strong interest to both the local and national
stakeholders.

Objectives:

● To construct a descriptive profile of patients referred to and engaging in UK’s outpatient
First Bridge Clinic.
● To determine whether in-hospital initiation of MOUD increases the likelihood of patients
being scheduled for an intake appointment with the First Bridge Clinic.
● To determine whether those who are already on MOUD are more likely to keep their
scheduled appointments with the First Bridge Clinic.
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Literature Review

OUD as a National Health Crisis

The opioid epidemic is a national health crisis affecting not only the public’s health but
also the social and economic well-being of the United States as a whole. Misuse of and addiction
to opioids has a direct impact on an individual's life and an indirect impact on all those
surrounding the affected individuals.

In the United States, drug overdoses resulted in 702,568 deaths during 1999-2017, with
56.8% of these deaths involving opioids. From 2016-2017 alone, death rates from all opioids
increased, with increases driven by synthetic opioids. In 2017, drug overdoses resulted in 70,237
deaths with 47,600 of these deaths involving opioids. This is a death rate of 14.9 per 100,000
persons. The 2017 rate was 12% higher than the previous year with increases in overdose deaths
seen across age groups, racial/ethnic groups, county urbanization levels, and in multiple states.1

Despite increased overdose deaths which have largely been attributed to contamination
with synthetic opioids, there have been improvements in other substance use disorder (SUD)related trends. In 2018, around 7.4% of the population aged 12 or older, or 20.3 million people,
were found to have an SUD. Of those with an SUD, an estimated 2.0 million people, or
approximately 0.8% of the population aged 12 and older, struggled with an OUD. This was a
decrease from the estimated OUD population number in 2017 which was estimated to be 2.1
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million. Furthermore, it was estimated that 3.7 % of people aged 12 and older, or 10.3 million
people, misused prescription pain relievers in 2018. This estimation also decreased from
estimates in 2017 which demonstrated that 11.4 million people had misused prescription pain
relievers. Additionally, another downward trend was observed in 2018 compared to previous
years: that of heroin usage. This observation was primarily due to the decline in heroin use
among adults aged 18-25 years old. In conclusion, the downward trends demonstrated in 2018
are congruent with the increased usage of and access to medication-assisted treatment (MAT) at
that time. 2

Federal and State Responses

As indicated above, the U.S opioid overdose epidemic continues to evolve. Significant
and substantial financial resources are required to reverse these trends. To address these trends
properly, the Opioid State Targeted Response (Opioid STR) grants, which were created by the
21st Century Cures Act, were developed by the Substance Abuse and Mental Health Services
Administration (SAMHSA) within the Department of Health and Human Services (DHHS). This
program began in 2017 and funded 57 states and territories. The grant provided formula funding
with the expectation that grantees would use the funding to address the national epidemic by
increasing access to treatment, reducing unmet treatment needs, and reducing opioid overdoserelated deaths. These goals were to be accomplished through the provision of prevention,
treatment, and recovery services for OUD. Opioid STR funding to states and territories was
provided over an initial two-year time period, with roughly $500 million being provided per
year. In the first year, grantees used funding to implement effective medication-assisted
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treatment, promote the use of naloxone and key prevention strategies, and build sustainable
systems of recovery support services across the country. Prevention efforts included
communications campaigns along with the use of proven community-based strategies.
Additionally, individuals with personal experience were utilized to augment all endeavors. These
people proved to enhance these recovery-based initiatives. Ultimately, states identified the need
to connect more Americans with evidence-based programs and practices proven to help those
with OUDs, and many sought to support the implementation of innovative models to do so. 3

Initial awardees of the funding were expected to participate in the Opioid STR national
evaluation. The national cross-site evaluation, conducted through contracted services, was
intended to capture the complexity of the states’ and territories’ response to the opioid crisis
within the two-year time frame of the grant. It provided SAMHSA with important information
regarding the implementation and impact of the grants as well as qualitative and quantitative data
components such as project director interviews and follow-up surveys plus analysis of biannual
data, respectively. The baseline survey was completed by 54 of 57 (95%) of Opioid STR project
directors and 55 of 57 (97%) follow-up surveys were completed. Preliminary data regarding the
start-up phase of the project demonstrated that nearly 30,000 individuals received evidencebased prevention services. Of significance, the grant recipients were successful in expanding new
medication access in several states and territories. Seven states added buprenorphine, six added
injectable naltrexone, five added methadone, five added oral naltrexone, and four added
buprenorphine/naloxone. Capacity for responding to the opioid crisis by the provision of
treatment increased in all states and territories. Over 118,000 individuals received Opioid STR
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funded OUD treatment services, while more than 33,000 individuals were able to access Opioid
STR funded recovery support services.

The national cross-site evaluation identified three main themes: state policy, partnerships
and collaborations, and sustainability. State Policy: Preliminary findings indicated that states
reported policy challenges when trying to implement opioid interventions. Furthermore, state
budget and legislative cycles, as well as protracted timeframes for hiring and procurement at the
state level presented implementation delays. Partnerships and Collaborations: While
approximately 70% of states and territories already operated an opioid task force, STR funds
were used to enhance these collaborations. The national evaluation identified this as being key in
adequately addressing OUD. Of interesting note, these collaborations were often initiated with
the support of state and territory leadership, including the governor and legislature.
Collaborations often included opioid workgroups with inter-departmental and inter-agency
participation. Small scale partnerships and community coalitions were also found to be effective.
Sustainability: The issue of sustainability was a key point in the successful implementation of the
Opioid STR programs and interventions. While it was known, at the time of implementation, that
Medicaid coverage and reimbursement for OUD and substance use disorder services was
important to the delivery of MOUD and recovery services, the cost of medications and
difficulties in obtaining authorization for insurance payments presented significant barriers.
Provider perceived burdens in obtaining reimbursement as well as high deductible plans were
also barriers to getting needed treatment to individuals. 4
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Of the states selected within each DHHS region to be sub-recipients of the cross-site
study, Kentucky was one of two states identified as implementing novel treatment approaches to
combat the opioid crisis. Kentucky’s approach highlights the ED bridge model, which links
patients discharged from EDs to treatment and recovery support services. Kentucky began by
implementing this model in three hospitals in three regions of the state, each with rates of
overdose exceeding the national average. UK was one of those three institutions, creating the
First Bridge Clinic in 2018 with state and federal support. The data collected from this clinic will
serve as a foundation for the remainder of this paper.

OUD in Kentucky

Kentucky has been significantly affected by the opioid epidemic and considered to be
one of the most affected states in the country. In 2016, the age-adjusted drug overdose fatality
rate in Kentucky was 33.5 deaths per 100,000 people, or 1,419 opioid overdose deaths. The
overdose death rate rose to 37.2 per 100,000 in 2017, an 11% increase from 2016. Kentucky was
ranked fifth in the nation for drug overdose fatality rate that year.5 Other needs demonstrated by
the Commonwealth of Kentucky prior to STS grant funding included the rapidly rising rates of
Neonatal Abstinence Syndrome and Hepatitis C.6,7 As a result, the opioid epidemic in Kentucky
was determined to be a top priority across both private and public sectors including all levels of
government, local, state, and federal. 8

The Emergency Department (ED) Bridge Model
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The evidence-based ED bridge model9 10 involves providing services following overdose
or opioid-related complications, including screening, brief intervention, buprenorphine/naloxone
induction, and linkage to ongoing care. In a randomized clinical trial, ED-initiated buprenorphine
treatment versus brief intervention and referral alone resulted in a significant increase in
engagement with addiction treatment, a reduction in self-reported illicit opioid use, and a
decreased utilization of inpatient addiction treatment services.11 Numerous studies have
documented that buprenorphine is an effective treatment for opioid withdrawal as well as an
agent that increases the likelihood of treatment engagement and retention; this research has led to
the medication’s widespread adoption.12 13

When the Commonwealth of Kentucky sought to implement their ED bridge program,
they chose three hospitals in three regions of the state, each with rates of overdose deaths
exceeding the national average.14 Kentucky’s bridge model was inclusive of the following four
elements:
•

Training and support of providers, including physicians, nurse practitioners, and hospital
staff, to support hospital-based buprenorphine inductions for patients in acute opioid
withdrawal (inpatient or ED).

•

Peer Support Specialists or other care navigator as members of the ED team. Evidence
has demonstrated the capacity of peers in promoting treatment engagement following
hospital discharge.15

•

A transitional outpatient clinic (“bridge clinic”) providing medical and psychiatric care
for patients leaving the hospital.

•

Allocation of funds for the distribution of naloxone in the ED and inpatient setting.16 17
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UKHealthcare’s First Bridge Clinic

UK was chosen as one of the three recipients for the ED bridge model funding. UKHC
launched the First Bridge Clinic in January 2018, created through a partnership between the
Center on Drug and Alcohol Research (CDAR), UKHC, and the Kentucky Cabinet of Health and
Family Services (KCHFS). The primary goal of the First Bridge Clinic was to save lives by
connecting individuals who presented to the ED or inpatient hospital service with complications
of OUD (e.g., overdose, withdrawal, abscess, or life-threatening infections such as endocarditis)
to treatment. Other goals included the provision of on-demand access to evidence-based care,
including efforts to decrease obstacles to care. And finally, the clinic attempts to stabilize the
patient, provide ancillary services, and ultimately BRIDGE them to treatment in the community.

Once patients are successfully engaged with the First Bridge Clinic, they receive a
multitude of wraparound services, including medical, psychiatric, psychosocial and recovery
support services. Naloxone training is provided along with harm reduction training and
buprenorphine education. The multidisciplinary team, including a nurse navigator, licensed
therapists, certified adult peer support specialists, waivered physicians and nurse practitioners,
works together to identify, engage, and retain patients with OUD in treatment. The idea of
“bridging” care begins at the first visit. Patient’s preferences are considered. An online service
that locates treatment centers throughout the state with availability is utilized in order to connect
patients with treatment close to their homes that is affordable and works with their insurance.
Warm hand-offs and follow-ups are provided for all transitions. Ultimately, the clinic aims to
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provide treatment in a safe, patient-centered, non-judgmental environment to empower patients
to achieve remission and recovery.

Summary

The UK First Bridge Clinic seeks to increase access to medication treatment for OUD in
order to decrease mortality and morbidity. By applying patient-centered, evidence-based
interventions aligned with SAMHSA’s new Treatment Improvement Protocol 63 “Medications
for Opioid Use Disorder,”18 the clinic has been able to provide much-needed services to address
local needs.

Patients served by UK’s Bridge Clinic are often complex with a myriad of medical,
psychiatric, and psychosocial needs in addition to OUD. Because of the early success of UK’s
First Bridge Clinic, additional research is needed to better understand the populations served and
opportunities for dissemination. This capstone will serve as a starting point to inform this need.
By creating a demographic profile of patients’ receiving referral to The First Bridge Clinic, we
will be taking the first step into ascertaining its effectiveness. And finally, because treatment
engagement as a primary outcome is important as it is the beginning step to a life of recovery, we
will endeavor to identify and characterize significant predictors of treatment initiation.

METHODS
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We conducted a retrospective chart review of clinical data that has been collected as part
of the usual course of patient care. The data utilized were collected from October 1, 2018 to
February 29th, 2020. This data has also been used to fulfill requirements by the funding sponsor
Kentucky Department of Behavioral Health, Developmental and Intellectual Disabilities. As the
clinical data had not been used for research prior to this project, we requested approval from the
UK Institutional Review Board (IRB). The project (IRB number 57593 “Bridging the gap:
Novel Models”) was approved by the UK IRB on 3/20/2020.

Data captured for First Bridge Clinic patients included the following: age, sex, race,
pregnancy status, veteran status, history of incarceration, initiation of medications for OUD, date
of initiation, type, dose, and duration of medication used, the treatment setting in which MOUD
began, whether naloxone was dispensed, whether relapse prevention education was provided,
whether peer support or recovery coaching was utilized, whether self-help and support groups
were utilized, whether recovery housing was utilized, continuing care, employment support, and
30-day retention in care after starting at the First Bridge Clinic.

Data came primarily from the clinical care surveillance system used by the First Bridge
Clinic. This system pulled data from the electronic medical record of UKHealthCare which
included Allscripts Sunrise Clinical Manager, Allscripts outpatient AEHR, McKesson PACS
system, lab tracker data base, paper charts, billing system, STS database, the UKHC Enterprise
Data Warehouse, and the Social Security Death Index.

17

Data were collected and entered into Microsoft Excel. Descriptive statistics (mean ±
standard deviation or numbers and percentages) were calculated for demographic characteristics;
this analysis was conducted for the entire study population, for all those who received and did
not receive an appointment, and for all those who kept and did not keep their first appointment.
Two-sample t-tests (continuous variables) and chi-square tests (categorical variables) were used
to compare characteristics (1) for individuals receiving appointments versus those who did not
and (2) for individuals who kept their appointment versus those who did not. Logistic regression
analysis was performed to examine predictor variables for scheduling and keeping first
appointments with the First Bridge Clinic.

Overall sample size, which was the total number of patients referred to the First Bridge
Clinic, was 974. Sample sizes for the analyses of patients with scheduled appointments and kept
appointments are listed in their respective tables. A p-value of 0.05 was used for statistical
significance. Seven subjects were excluded from analysis as they still had appointments pending.

Results

Table 1 displays the demographic characteristics of the First Bridge Clinic patient
population. Average age was 36 years old. There were slightly more males (57%) than females
and the population was largely white (90.8%) with only 6.4% of the population black or African
American, 0.3% Asian, 0.2% Native Hawaiian or Pacific Islander, 0.5% more than one race, and
1.8% unknown. Pregnancy status was known on 246 female patients and only 2 (0.8%) were
pregnant. Veteran status (defined as being a veteran, a service member, or a family member of a
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veteran) was known for 400 study patients and only 1 person was a veteran. Of 417 patients
asked whether they had been released from a correctional facility in the past 30 days, only 4
answered yes. Ten of 427 patients reported homelessness. There were 253 patients on MOUD at
the time of referral to the First Bridge Clinic. The majority of these patients were started on
MOUD while in the hospital, either by the inpatient ACES service or in the emergency
department. Buprenorphine was the preferred MOUD as 98.4% of the 253 individuals were
started on this medication. There was only 1 person on methadone at the time of referral and 3 on
naltrexone. Volume of quarterly referrals to the First Bridge Clinic increased from the beginning
of 2018 (clinic inception) to the end of 2019.
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Table 1. Demographic Characteristics of All patients Receiving
First Bridge Clinic Referral
Characteristic
N=974*
Age (yr) ± SD
36 ± 9.9
Characteristic (Categorical)
Male sex, No. (%)
555 (57%)
Race, No. (%)
White
884 (90.8%)
Black or African American
62 (6.4%)
Asian
3 (0.3%)
Native Hawaiian or Pacific
Islander
2 (0.2%)
More Than One Race
5 (0.5%)
Unknown
18 (1.8%)
a
Hispanic Or Latino, No. (%)
7 (0.7%)
Pregnant,b No. (%)
2 (0.8%)
Veteran, Service Member, or
Family Member,c No. (%)
1 (0.3%)
Released from Correctional
Facility in the past 30 days,d No.
(%)
4 (1%)
Homeless,e No. (%)
10 (2.3%)
MOUD Initiated, No. (%)
No
721 (74.0%)
Yes
253 (26%)
f
Type of MOUD, No. (%)
Buprenorphine
249 (98.4%)
Methadone
1 (0.4%)
Naltrexone
3 (1.2%)
g
Yearly Quarters, No. %
1 (Jan-Mar) 2018
25 (2.8%)
2 (Apr-Jun) 2018
51 (5.8%)
3 (Jul-Sept) 2018
109 (12.4%)
4 (Oct-Dec) 2018
135 (15.4%)
1 (Jan-Mar) 2019
99 (11.3%)
2 (Apr-Jun) 2019
155 (17.7%)
3 (Jul-Sept) 2019
158 (18.0%)
4 (Oct-Dec) 2019
146 (16.6%)
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*N is the sample size of people receiving referral to the First Bridge Clinic unless indicated by
alphabetic superscripts.
a
N=973 patients. 1 subject with missing data.
b
N=246 female patients. 173 female patients with missing data.
c
N=400 patients. 574 patients with missing data.
d
N=417 patients. 557 patients with missing data.
e
N=427 patients. 547 patients with missing data.
f
N=253 patients. 609 not began on MOUD at time of referral.
g
N=878. 96 patients from 2020 were removed as quarter 1 was not complete at time of analysis.

Table 2 displays the characteristics of patients who received and those who did not
receive an appointment to the First Bridge Clinic. The variables of age, sex, race, release from a
correctional facility in the past 30 days, homelessness, whether a patient was already on MOUD,
and the type of MOUD given were all significantly different between the two groups. Statistical
significance was not determined for yearly quarters.
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Table 2. Comparison of Demographic Characteristics Between Patients Who Received and Who Did Not
Receive an Appointment to the First Bridge Clinic
No Appointment
Appointment Scheduled,
Characteristic (Continous)
Scheduled, N=484*
N=490*
P-value
Average Age (yr) ± SD
35.94 ± 9.89
37.75 ± 9.82
0.004
Characteristic (Categorical)
Sex, No. (%)
0.036
Male
292 (60.3%)
263 (53.7%)
Female Sex
192 (39.7%)
227 (46.3%)
Race, No. (%)
0.04
White
430 (88.8%)
454 (92.7%)
Minorities
54 (11.2%)
36 (7.3%)
a
Hispanic Or Latino, No. (%)
0.247
No
478 (99.0%)
488 (99.6%)
Yes
5 (1.0%)
2 (0.4%)
b
Pregnant, No. (%)
0.49
No
47 (100.0%)
197 (99.0%)
Yes
0 (0.0%)
2 (01.0%)
Veteran, Service Member, or
Family Member,c No. (%)
0.879
No
9 100%)
390 (99.7)
Yes
0 (0%)
1 (0.3%)
Released from Correctional
Facility in the past 30 days, d
No. (%)
<0.0001
No
6 (75%)
407 (99.5%)
Yes
2 (25%)
2 (0.5%)
e
Homeless, No. (%)
<0.0001
No
16 (80.0%)
401 (98.5%)
Yes
4 (20.0%)
6 (1.5%)
Already on MOUD, No. (%)
<0.0001
No
478 (98.8%)
243 (49.6%)
Yes
6 (1.2%)
247 (50.4%)
f
Type of MOUD, No. (%)
<0.0001
Buprenorphine
5 (83.3%)
244 (98.8%)
Methadone
1
0
Naltrexone
0
3
Yearly Quarters,g No. ( %)
1 (Jan-Mar) 2018
6 (1.37%)
19 (4.33%)
2 (Apr-Jun) 2018
25 (5.70%)
26 (5.92%)
3 (Jul-Sept) 2018
72 (16.40%)
37 (8.43%)
4 (Oct-Dec) 2018
62 (14.12%)
73 (16.63%)
1 (Jan-Mar) 2019
51 (11.62%)
48 (10.93%)
2 (Apr-Jun) 2019
77 (17.54%)
78 (17.77%)
3 (Jul-Sept) 2019
78 (17.77%)
80 (18.22%)
4 (Oct-Dec) 2019
68 (15.49%)
78 (17.77%)
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*N is the sample size of patients either not receiving or receiving appointments to the First
Bridge Clinic unless indicated by alphabetic superscripts.
a
N= 973 patients. 1 subject with missing data.
b
N= 246 female patients. 173 female patients with missing data.
c
N= 400 patients. 574 patients with missing data.
d
N= 417 patients. 557 patients with missing data.
e
N= 427 patients. 547 patients with missing data.
f
N=365 patients. 609 patients with missing data.
g
N= 878 total patients. Subject referral dates from 2020 were removed due to incomplete quarter
at time of analysis. There were 439 patients who did not have appointments scheduled, and there
were 439 patients who did have appointments scheduled.

Table 3 displays the characteristics of those subjects who did not and did keep their first
appointment with the First Bridge Clinic. The only statistically significant difference between
these two groups was age.
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Table 3. Comparison of Demographic Characteristics of All Patients Who Kept Their First Appointment
Vs. Those Who Did Not to the First Bridge Clinic
Did Not Keep
Kept Appointment,
Characteristic (Continous)
Appointment, N=208*
N=282*
P-value
Average Age (Yr) ± SD
36.59 ± 9.08
38.52 ± 10.20
0.028
Characteristic (Categorical)
Sex, No. (%)
0.574
Female Sex, No. (%)
99 (47.60%)
127 (45.00%)
Male Sex, No. (%)
109 (52.40%)
155 (55.00%)
Race, No. (%)
0.921
White
193 (92.80%)
261 (92.60%)
Minorities
15 (7.20%)
21 (7.40%)
Hispanic Or Latino, No. (%)
0.224
No
208 (100.0%)
280 (99.3)
Yes
0 (0.0%)
2 (0.7%)
a
Pregnant, No. (%)
0.285
No
72 (100.0%)
125 (98.4%)
Yes
0 (0.0%)
2 (1.6%)
Veteran, Service Member,
or Family Member,b No. (%)
0.513
No
117 100.00%)
273 (99.60%)
Yes
0 (0.00%)
1 (0.40%)
Released from Correctional
Facility in the past 30 days, c
No. (%)
0.567
No
127 (99.20%)
280 (99.60%)
Yes
1 (0.80%)
1 (0.40%)
d
Homeless, No. (%)
0.419
No
129 (99.2%)
272 (98.2%)
Yes
1 (0.8%)
5 (1.8%)
Already on MOUD, No. (%)
0.735
No
105 (50.50%)
138 (48.90%)
Yes
103 (49.50%)
144 (51.10%)
Type of MOUD, e No. (%)
0.141
Buprenorphine
103 (100.00%)
141 (97.9%)
Methadone
0
0
Naltrexone
0
3
Yearly Quarters,f No. (%)
1 (Jan-Mar) 2018
7 (3.87%)
12 (4.65%)
2 (Apr-Jun) 2018
7 (3.87%)
19 (7.36%)
3 (Jul-Sept) 2018
13 (7.18%)
24 (9.30%)
4 (Oct-Dec) 2018
21 (11.60%)
52 (20.16%)
1 (Jan-Mar) 2019
20 (11.05%)
28 (10.85%)
2 (Apr-Jun) 2019
29 (16.02%)
50 (19.38%)
3 (Jul-Sept) 2019
43 (23.76%)
36 (13.95%)
4 (Oct-Dec) 2019
41 (22.65%)
37 (14.34%)
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*N is the sample size of patients either not keeping or keeping appointments to the First Bridge
Clinic unless indicated by alphabetic superscripts.
a
N= 199 female patients who had scheduled appointments.
b
N= 391 patients who had scheduled appointments.
c
N= 409 patients who had scheduled appointments.
d
N= 407 patients who had scheduled appointments.
e
N= 247 patients who had scheduled appointments.
f
Out of 439 total patients. Subject referral dates from 2020 were removed due to incomplete
quarter at time of analysis. There were 181 patients who did not keep their appointments as 27
patients who did not keep their appointment in 2020 were removed. There were 258 patients who
did keep their appointments as 24 patients who kept their appointments in 2020 were removed.

Statistically significant findings from Table 2 were used to inform variables (age, sex,
race) included in the logistic regression model shown in Table 4. Other variables that were
statistically significant were not included because of high numbers of missing values.

Table 4. Logistic Regression Model for Appointments Scheduled

Age
Male Sex
White Race
MOUD Already

Odds Ratio
1.024
0.814
1.403
81.969

P-Value
0.002
0.193
0.224
<0.0001

95% CI
1.009-1.039
0.597-1.110
0.813-2.422
35.894-187.188

Findings in Table 4 suggests that those who were on MOUD at the time of referral,
defined as those who were either initiated onto MOUD in the ED or while an inpatient, or those
who were already on MOUD at the time they were seen in the hospital (ED or inpatient), were
significantly more likely to receive an appointment to the First Bridge Clinic. Older age was also
associated with increased likelihood of an appointment.
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To determine whether those already on MOUD were more likely to keep their first
appointment with the First Bridge Clinic, the same predictor variables (age, sex, race, MOUD
already) were included into the logistic regression model. The results (Table 5) suggest that those
already on MOUD did not have a statistically significant increased likelihood of keeping this
first appointment. Once again, older age was associated with increased likelihood of keeping first
appointment.

Table 5. Logistic Regression Model for Appointments Kept

Age
Male Sex
White Race
MOUD Already

Odds Ratio
1.021
1.077
0.917
1.102

P-Value
0.03
0.689
0.808
0.597

95% CI
1.002-1.041
0.749-1.548
0.458-1.837
0.768-1.583

Discussion

Previous empirical research demonstrates the difficulty of engaging people with OUD in
treatment. 19 Furthermore, there is disagreement over the definition of successful treatment. In
this study, we sought to determine whether MOUD induction in the hospital setting
(ED/inpatient) would increase the likelihood that a person would present to their First Bridge
Clinic appointment as previous literature suggests.20 We found no significant difference in
appointment adherence between those who were already on MOUD in the hospital setting versus
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those who were not (Table 5). However, those who were already on MOUD at the time of
referral were much more likely to be referred for an appointment (Table 4). This finding is very
important in that it highlights that people are being given proper follow-up for treatment of their
OUD. Getting an actual concrete appointment as opposed to a list of potential referral facilities
could ultimately help to engage a highly stigmatized and vulnerable population.

Our findings are consistent with the primarily rural population served by the UK
Chandler and Good Samaritan hospitals; these patients face significant transportation barriers
that may limit their ability to keep appointments. We have found that rural patients given next
day follow-up appointments are more likely to return for their outpatient visit. 21 However, the
large majority of First Bridge Clinic patients were scheduled for appointments that were several
days to a few weeks after initial referral date.

It is also important to note that many patients referred to The First Bridge Clinic are
dealing with other very serious sequelae of their substance abuse such as infective endocarditis,
abscesses, or other health conditions that could preclude their ability to successfully attend their
first scheduled follow up appointment. The inpatient consult service, ACES, is the largest source
of referrals to the clinic. Those presenting to the ED, but not receiving subsequent hospital
admission, are likely better able to attend their follow up appointments. Increased referrals from
ED providers could substantially reduce no-show rates.

And finally, Kentucky administrative regulations regarding induction onto buprenorphine
also made successful implementation of the ED bridge model challenging. Currently,
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administrative regulation requires any dispensing physician to obtain and record a complete
patient evaluation, including a comprehensive laboratory work up including screening for HIV
and HCV, as well as other administratively heavy and time consuming tasks.22 Due to the
emergent and fast-paced environment of the ED, these regulations likely inhibited referrals. In
contrast, the inpatient consult service, composed largely of board-certified addiction medicine
physicians and data-waivered providers, was better positioned to meet the state-mandated
requirements.

Analysis of patient demographics reveals a largely Caucasian population, consistent with
the location of the study site. UKHC hospitals in Lexington, Kentucky primarily serve a rural
Appalachian population, lacking racial diversity. This fact may affect generalizability of study
results.

The receipt of appointment analysis revealed several statistically significant differences
in patients who did and did not receive appointments (Table 2). Patients who were of older age,
male sex, and white race were more likely to receive appointments. Unfortunately, recently
incarcerated individuals, as well as individuals who were homeless, were less likely to receive an
appointment. Homeless people are known to use the ED for routine, non-emergent medical
needs, and furthermore, they are three times more likely to use the ED than non-homeless
people.23 They also often have substance abuse issues.24 Therefore, one would think, homeless
individuals would receive follow up appointments as a priority. However, homeless people often
face significant barriers to accessing health care. Competing demands for shelter, food, and
safety supersede the need to obtain primary medical care for many homeless individuals.25 Poor
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compliance with provider recommendations can contribute significantly to provider burnout and
frustration. We can therefore conclude that perhaps provider dissatisfaction and bias contributed
to the small number of referrals given to homeless individuals.

The comparison of demographic characteristics between patients who received an
appointment and those who did not also illuminated that those started on MOUD were more
likely to receive an appointment. In addition, there was a statistically significant difference found
between the groups for the variable type of MOUD. Those on buprenorphine were more likely to
receive a scheduled appointment. Ultimately, these results are congruent with the patient
population receiving referral: individuals with an OUD. The fact that patients who were either
inducted onto a highly controlled substance or who were already receiving an MOUD received a
referral appointment indicates that this population is being given the opportunity for proper
follow up care.

Finally, Information on the yearly quarters was included into the analysis to highlight the
increasing utilization of the First Bridge Clinic over time. Upward trends are demonstrated
through the year 2018 and 2019. It appears that quarter 1 in 2019 demonstrated a slight
backwards pattern, but resumed to the upward trend by quarter 2 (Table 1). While no statistical
analysis was conducted when comparing groups of those who received appointments and those
who kept appointments, overall, there appeared be upward trends, with a few exceptions,
demonstrated for all groups. These overall upward trends demonstrate that provider and
institutional acceptance grew overtime. Familiarity and comfort with the model appeared to be
adopted as part of the care for those with OUD over the two year period.
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Limitations
We were unable to control for other factors that may affect receipt of appointment or no
show. For example, we did not have information on whether or not a patient received peer
support, recovery services, or social support ancillary services in the hospital setting. Data on the
patient’s hospital course has not yet been linked to the outpatient Bridge Clinic’s database, but
could provide useful information in the future. Furthermore, the study lacks concrete information
on when MOUD was initiated: in the inpatient/ED setting or prior to hospital presentation. We
were also unable to differentiate the referral source between the ED and the inpatient consult
service. Finally, we were unable to include additional important outcomes, including MOUD
initiation after referral to the First Bridge Clinic and 30-day retention rates.

Recommendations
Our primary recommendation is for additional analyses. The variable of interest, MOUD
at the time of referral, was not found to increase the likelihood of presentation for first follow up
appointment with the First Bridge Clinic. Because this finding is somewhat incongruent with
previous evidence, we recommend constructing a survival model to determine if increasing the
length of time between initial referral and scheduled follow up appointments significantly
reduces appointment adherence. If significant, implementation of a fast-track follow up system
could be vitally important to improve treatment engagement outcomes.
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Increasing ED referrals to The First Bridge Clinic are also paramount. We recommend
continued work with state government, which was so vital to the implementation of the program,
to reduce MOUD-associated administrative burdens to ED providers. In addition, frequent and
reassuring feedback and education to ED staff regarding the positive and potentially impactful
outcomes of the program could increase the referrals, as well as debunk myths and stigma of
addiction.

Future efforts to engage especially vulnerable populations, including homeless and those
recently incarcerated, are needed. Reasons for reduced referrals for members of this population
should be elucidated and addressed.

Conlusions and Implications for Pubic Health Practice
The volume of visits to the First Bridge Clinic was demonstrated to increase over time
highlighting the substantial need for this unique service. Significant administrative and
bureaucratic barriers had to be overcome at all levels of government as well as both the private
and public sector to be able to implement an ED-initiated MOUD program at the University of
Kentucky. The creation of an inpatient consult service has helped augment referrals to the First
Bridge Clinic as significant instituational and state level regulations have made utilization by
UKHealthcare’s EDs challenging. Streamlining the referral process could help to overcome this
impediment, thus substantially increasing referrals. While the consult service seemingly provided
a sufficient referral source, oftentimes these patients had many medical comorbities and illnesses
that could have interferred with their ability to attend their first scheduled outpatient
appointments. Patients receiving referrals directly from the ED are likely to have fewer
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comorbidities and better able to seek follow up outpatient care. Therefore, increased referrals
from the ED could substantially reduce no-show rates at the First Bridge Clinic. Additionally,
rural patients face many barriers to follow up care. Providing same or next day outpatient
appointments can increase the likelihood they are able to initiate outpatient care. In conclusion,
amongst other factors, MOUD as a component in increasing a patient’s likelihood for attendance
at their first follow up appointment was not found to be significant. However, patients already on
MOUD were more likely to be referred for outpatient treatment suggesting that interventions
which increase MOUD initiation in the hospital will ultimately result in more people engaging in
outpatient treatment.
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